fashion -WSS

fashion

author：focus 2025-09-03 05:26:53 - browse：61966

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： PBM executives asked to testify by House panel

hotspot

knowledge

WSS

As billionaires fund anti

AltruBio raises $225 million to develop ulcerative colitis drug

AltruBio raises $225 million to develop ulcerative colitis drug

The effects of a landmark ruling on DNA ownership are becoming clearer

H.R. 3 is the wrong path to lower drug costs

'Null' research findings aren't empty of meaning. Let's publish them

focus

fashion

knowledge

Continuity nursing helped my family in our darkest PICU moments

Flint parents haunted by uncertainty, fears of lead poisoning

Supreme Court strikes down use of affirmative action

Has Bernie Sanders reached the limit of his pharma bullying effort?

Novavax promises a turnaround & Lilly roils the obesity market

A controversial new treatment promises to make little people taller

Continuity nursing helped my family in our darkest PICU moments

The creative science of coining drug names

United colonoscopy coverage change 'may cost lives,' doctors say

Florida officials tell state schools to teach AP Psychology 'in its entirety'

hotspot

AI for drug discovery: Experts on separating hype from reality

Medicare slashes safety net hospital payments by nearly $1 billion

'Null' research findings aren't empty of meaning. Let's publish them

A controversial new treatment promises to make little people taller

Brain MRIs reveal impact of 'toxic stress' on Black children

Medicare slashes safety net hospital payments by nearly $1 billion

hotspot

entertainment

knowledge

focus